Orforglipron: a comprehensive review of an oral small-molecule GLP-1 receptor agonist for obesity and type 2 diabetes
Studies with longer follow-up duration are required to further investigate the potential factors associated weight change after discontinuation of treatment
206,487 These changes lead to a reduction in the production of non-esterified fatty acids (LCFAs) and glucose, as well as a decrease in the synthesis of VLDL (Very Low-Density Lipoprotein)
Mix Greek yogurt with garlic, lemon juice, Parmesan cheese, and Italian seasoning
Common Saxenda side effects include nausea, vomiting, diarrhea, constipation, headaches, heartburn, runny nose, sneezing, cough and fatigue
Cardiovascular effects: Retatrutide's glucagon receptor agonism may influence heart rate and blood pressure